|
|
| What Funding is available to early and midstage bioscience companies? |
icon_not_available.gif |
| Presentation 1 Attachment |
|
| The role of public markets in financing biotech |
icon_not_available.gif |
| Presentation 2 Attachment |
|
| Fund raising options for listed companies - alternative instruments and structures |
icon_not_available.gif |
| Presentation 3 Attachment |
|
| Presentation 4 Attachment |
|
BioFinance Europe, London, UK
BioFinance, Europe, London, UK
|